Press coverage about AmerisourceBergen (NYSE:ABC) has been trending somewhat positive recently, according to Accern Sentiment. The research firm scores the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. AmerisourceBergen earned a daily sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the company an impact score of 45.7861186466923 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the news articles that may have impacted Accern Sentiment Analysis’s rankings:
- AmerisourceBergen Corp. (ABC) Holdings Lifted by Employees Retirement System of Texas (americanbankingnews.com)
- AmerisourceBergen Corp. (ABC) Position Reduced by Brown Advisory Inc. (americanbankingnews.com)
- [$$] AmerisourceBergen, Walgreens fall after deal talks reportedly end (finance.yahoo.com)
- AmerisourceBergen, Walgreens shares slide after report that talks have ended without a deal (finance.yahoo.com)
- AmerisourceBergen stock drops as Walgreens takeover talks fizzle (finance.yahoo.com)
Shares of AmerisourceBergen (ABC) traded down $2.48 during trading on Wednesday, reaching $95.16. The company had a trading volume of 1,432,256 shares, compared to its average volume of 2,580,000. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.50 and a current ratio of 0.95. The company has a market capitalization of $20,900.00, a price-to-earnings ratio of 54.38, a P/E/G ratio of 1.61 and a beta of 1.02. AmerisourceBergen has a 1 year low of $71.90 and a 1 year high of $106.27.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 5th. Investors of record on Tuesday, February 20th will be issued a $0.38 dividend. This represents a $1.52 annualized dividend and a yield of 1.60%. The ex-dividend date is Friday, February 16th. AmerisourceBergen’s dividend payout ratio is currently 86.86%.
ABC has been the topic of several research reports. ValuEngine raised AmerisourceBergen from a “hold” rating to a “buy” rating in a research report on Tuesday, October 31st. Needham & Company LLC dropped their target price on AmerisourceBergen from $93.00 to $86.00 and set a “buy” rating on the stock in a research report on Monday, November 6th. Robert W. Baird reaffirmed a “buy” rating and set a $96.00 target price on shares of AmerisourceBergen in a research report on Monday, November 6th. Deutsche Bank initiated coverage on AmerisourceBergen in a research report on Monday, December 4th. They set a “buy” rating and a $97.00 target price on the stock. Finally, Cowen set a $107.00 target price on AmerisourceBergen and gave the stock a “buy” rating in a research report on Tuesday, December 12th. One analyst has rated the stock with a sell rating, five have given a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $102.46.
In related news, Director Richard W. Gochnauer sold 2,000 shares of the business’s stock in a transaction dated Wednesday, December 13th. The stock was sold at an average price of $88.00, for a total value of $176,000.00. Following the completion of the sale, the director now directly owns 12,947 shares of the company’s stock, valued at $1,139,336. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Tim G. Guttman sold 11,600 shares of the business’s stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $85.73, for a total value of $994,468.00. Following the completion of the sale, the chief financial officer now directly owns 56,436 shares of the company’s stock, valued at $4,838,258.28. The disclosure for this sale can be found here. Over the last three months, insiders sold 220,396 shares of company stock valued at $20,091,915. 27.30% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION WARNING: This report was first posted by Ticker Report and is the property of of Ticker Report. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.tickerreport.com/banking-finance/3229135/amerisourcebergen-abc-earning-somewhat-favorable-media-coverage-study-finds.html.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.